Financial giants have made a conspicuous bearish move on Abbott Laboratories. Our analysis of options history for Abbott Laboratories ABT revealed 19 unusual trades.
Delving into the details, we found 5% of traders were bullish, while 94% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $1,049,319, and 16 were calls, valued at $598,046.
Projected Price Targets
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $90.0 to $105.0 for Abbott Laboratories during the past quarter.
Volume & Open Interest Trends
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Abbott Laboratories's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Abbott Laboratories's significant trades, within a strike price range of $90.0 to $105.0, over the past month.
Abbott Laboratories Option Activity Analysis: Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| ABT | PUT | TRADE | BULLISH | 05/17/24 | $105.00 | $498.8K | 1.3K | 585 |
| ABT | PUT | TRADE | BEARISH | 05/17/24 | $105.00 | $494.4K | 1.3K | 5.0K |
| ABT | PUT | SWEEP | BEARISH | 05/17/24 | $105.00 | $55.9K | 1.3K | 585 |
| ABT | CALL | TRADE | NEUTRAL | 01/17/25 | $90.00 | $53.8K | 753 | 0 |
| ABT | CALL | TRADE | NEUTRAL | 01/17/25 | $90.00 | $53.6K | 753 | 40 |
About Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Having examined the options trading patterns of Abbott Laboratories, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
Current Position of Abbott Laboratories
- With a volume of 773,801, the price of ABT is up 0.85% at $113.4.
- RSI indicators hint that the underlying stock may be approaching oversold.
- Next earnings are expected to be released in 29 days.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Abbott Laboratories, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
